Addressing a New Drug Target

  • Author: ChemPlusChem
  • Published Date: 25 July 2015
  • Source / Publisher: ChemPlusChem/Wiley-VCH
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
thumbnail image: Addressing a New Drug Target

Related Societies

The resistance of Gram-negative bacteria to multiple drugs poses a serious threat to global health. One approach to tackling bacterial infections is to focus on inhibiting key bacterial enzymes and their active sites. Gyrase B, an enzyme not present in humans, is a well-validated target for developing antibacterial drugs but currently, no associated inhibitory drugs are on the market.


Alvin Hung and colleagues, A*STAR Experimental Therapeutics Centre, Singapore, have applied a combination of biophysical techniques to address this problem. First, a library of 1800 compounds was screened by differential scanning fluorimetry against a truncated version of Escherichia coli gyrase B. Fourteen fragments were identified and their binding was studied by isothermal titration calorimetry, NMR techniques, and X-ray crystallography. Modifications on a low-affinity fragment (KD = 233 µM, IC50 = 628 µM) led to the development of a new class of potent sub-micromolar inhibitors (IC50 = 160 nM) against gyrase B based on the phenyl aminopyrazole scaffold.


The picture shows the co-crystal structure of the pyrazole-based inhibitor in the active site of a gyrase B surrogate. As the urgency for devising new antibiotics grows, these compounds may provide starting points for drug development. Further optimization will be required to generate more potent and cell-permeable bacteria-active compounds.


 

This research can be found in a special issue of ChemPlusChem published in honor of Singaporeʼs Golden Jubilee.
The special issue is free to view in August 2015.

 

Article Views: 3379

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission. more

Follow on Facebook Follow on Twitter Follow on YouTube Follow on LinkedIn Follow on Instagram RSS Sign up for newsletters

Magazine of Chemistry Europe (16 European Chemical Societies) published by Wiley-VCH